Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.

Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, Tanabe T, Naruoka A, Kamada F, Serizawa M, Hatakeyama K, Matsumura K, Ohnami S, Maruyama K, Mochizuki T, Kusuhara M, Shiomi A, Ohde Y, Terashima M, Uesaka K, Onitsuka T, Nishimura S, Hirashima Y, Hayashi N, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Nakagawa M, Ishida Y, Sugino T, Takahashi M, Akiyama Y.

Cancer Sci. 2019 Dec 21. doi: 10.1111/cas.14290. [Epub ahead of print]

2.

Reliability and validity of a Japanese version of the psychosocial assessment tool for families of children with cancer.

Tsumura A, Okuyama T, Ito Y, Kondo M, Saitoh S, Kamei M, Sato I, Ishida Y, Kato Y, Takeda Y, Akechi T.

Jpn J Clin Oncol. 2019 Dec 13. pii: hyz181. doi: 10.1093/jjco/hyz181. [Epub ahead of print]

PMID:
31836884
3.

Solution to a complex problem after failed limb salvage surgery of the distal femur: A case report describing the tibial turn-up procedure.

Lim CY, Katagiri H, Murata H, Wasa J, Miyagi M, Ishida Y, Takahashi M.

J Orthop Sci. 2019 Sep 25. pii: S0949-2658(19)30267-2. doi: 10.1016/j.jos.2019.08.016. [Epub ahead of print] No abstract available.

PMID:
31563427
4.

Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver.

Sanoh S, Tamura Y, Fujino C, Sugahara G, Yoshizane Y, Yanagi A, Kisoh K, Ishida Y, Tateno C, Ohta S, Kotake Y.

Biol Pharm Bull. 2019;42(8):1366-1375. doi: 10.1248/bpb.b19-00249.

5.

In situ needle deflection technique using a steerable introducer for site-selective radiofrequency transseptal puncture.

Itoh T, Kimura M, Ishida Y, Tomita H.

J Arrhythm. 2019 May 7;35(3):565-567. doi: 10.1002/joa3.12191. eCollection 2019 Jun.

6.

Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.

Honda Y, Katagiri H, Takahashi M, Murata H, Wasa J, Hosaka S, Ishida Y, Ito I, Muramatsu K, Mochizuki T, Matsuyama Y, Yamaguchi K.

Int J Clin Oncol. 2019 Nov;24(11):1468-1478. doi: 10.1007/s10147-019-01492-0. Epub 2019 Jul 1.

PMID:
31264078
7.

Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.

Osawa M, Uchida T, Imamura M, Teraoka Y, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Ishida Y, Tateno C, Miyayama Y, Hijikata M, Chayama K.

J Gen Virol. 2019 Jul;100(7):1123-1131. doi: 10.1099/jgv.0.001268. Epub 2019 Jun 14.

PMID:
31199224
8.

Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP.

Makokha GN, Abe-Chayama H, Chowdhury S, Hayes CN, Tsuge M, Yoshima T, Ishida Y, Zhang Y, Uchida T, Tateno C, Akiyama R, Chayama K.

Sci Rep. 2019 Jun 11;9(1):8462. doi: 10.1038/s41598-019-44934-5.

9.

Nonendocardial Isthmus Involving a Protected Part Within the EndocardialĀ Scar in an Ischemic Ventricular Tachycardia.

Itoh T, Kimura M, Ishida Y, Tomita H.

JACC Clin Electrophysiol. 2019 May;5(5):637-638. doi: 10.1016/j.jacep.2019.01.010. No abstract available.

PMID:
31122388
10.

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection.

Tsuge M, Uchida T, Walsh K, Ishida Y, Tateno C, Kumar U, Glenn JS, Koh C, Heller T, Uprichard SL, Dahari H, Chayama K.

Viruses. 2019 Mar 15;11(3). pii: E263. doi: 10.3390/v11030263.

11.

Registration-directed phase 1/2 trial of irinotecan for pediatric solid tumors.

Makimoto A, Mugishima H, Taga T, Ishida Y, Nagatoshi Y, Ida K, Kumagai M, Kimura T, Ohashi Y, Kaneko M.

Pediatr Int. 2019 May;61(5):453-458. doi: 10.1111/ped.13826. Epub 2019 May 14.

PMID:
30859690
12.

Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.

Ishida Y, Kakuni M, Bang BR, Sugahara G, Lau DT, Tateno-Mukaidani C, Li M, Gale M Jr, Saito T.

J Interferon Cytokine Res. 2019 Mar;39(3):133-146. doi: 10.1089/jir.2018.0103. Erratum in: J Interferon Cytokine Res. 2019 May;39(5):315.

PMID:
30844328
13.

Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates via a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice.

Watari R, Kakiki M, Yamasaki C, Ishida Y, Tateno C, Kuroda Y, Ishida S, Kusano K.

Biol Pharm Bull. 2019;42(3):348-353. doi: 10.1248/bpb.b18-00582.

14.

Chimeric mice with human hepatocytes: A new system for genotoxicity studies.

Tateno C, Fukumuro M, Masumori S, Kakuni M, Ishida Y, Shimada T, Hayashi M.

Mutat Res Genet Toxicol Environ Mutagen. 2019 Mar;839:9-12. doi: 10.1016/j.mrgentox.2019.01.003. Epub 2019 Jan 14.

PMID:
30744813
15.

Differential growth of craniofacial and tibial bones to sympathetic hyperactivity-related hypertension in rats.

Uchikawa Y, Hosomichi J, Suzuki JI, Yamaguchi H, Ishida Y, Hatano K, Usumi-Fujita R, Shimizu Y, Kaneko S, Uesugi S, Ono T.

Arch Oral Biol. 2019 Mar;99:73-81. doi: 10.1016/j.archoralbio.2019.01.001. Epub 2019 Jan 3.

PMID:
30640030
16.

Interpolated Purkinje potentials recorded at a successful ablation site of a fascicular premature ventricular contraction during sinus rhythm.

Itoh T, Kimura M, Ishida Y, Tomita H.

Europace. 2019 May 1;21(5):715. doi: 10.1093/europace/euy296. No abstract available.

PMID:
30590443
17.

Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model.

Ye X, Tateno C, Thi EP, Kakuni M, Snead NM, Ishida Y, Barnard TR, Sofia MJ, Shimada T, Lee ACH.

ACS Infect Dis. 2019 May 10;5(5):738-749. doi: 10.1021/acsinfecdis.8b00192. Epub 2018 Nov 20.

PMID:
30408957
18.

A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers.

Watari R, Kakiki M, Oshikata A, Takezawa T, Yamasaki C, Ishida Y, Tateno C, Kuroda Y, Ishida S, Kusano K.

J Toxicol Sci. 2018;43(8):521-529. doi: 10.2131/jts.43.521.

19.

Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure.

Teraoka Y, Uchida T, Imamura M, Hiraga N, Osawa M, Kan H, Saito Y, Tsuge M, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Miki D, Ochi H, Ishida Y, Tateno C, Chayama K.

J Gen Virol. 2018 Aug;99(8):1058-1065. doi: 10.1099/jgv.0.001091. Epub 2018 Jun 19.

PMID:
29916799
20.

The whole transcriptome effects of the PPARĪ± agonist fenofibrate on livers of hepatocyte humanized mice.

de la Rosa Rodriguez MA, Sugahara G, Hooiveld GJEJ, Ishida Y, Tateno C, Kersten S.

BMC Genomics. 2018 Jun 7;19(1):443. doi: 10.1186/s12864-018-4834-3.

Supplemental Content

Loading ...
Support Center